Scott D Kuduk
Inventor
Stats
- 75 US patents issued
- 114 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 75 US Patents Issued
- 114 US Applications Filed
- 390 Total Citation Count
- May 31, 2023 Most Recent Filing
- Oct 20, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1
1 2 | 1999
2000 2001 |
| MERCK & CO., INC. | 4
| 2005
|
| Merck Sharp Dohme Corp. | 2
| 2011
|
| MERCK SHARP & DOHME LTD. | 1
| 2010
|
| MERCK SHARP & DOHME CORP. | 6
2 2 2 18 18 12 24 24 26 19 | 2003
2004 2006 2008 2009 2010 2011 2012 2013 2014 2015 |
| WUXIAPPTEC (SHANGHAI) CO. LTD. | 2
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| DOYLESTOWN, PA, US | Jun 23, 16 - Jun 30, 16 |
| Doylestown, PA, US | Jul 04, 17 - Nov 28, 17 |
| HARLEYSVILLE, NJ, US | Oct 15, 15 - Jul 28, 16 |
| HARLEYSVILLE, PA, US | Jan 21, 16 - Nov 16, 17 |
| Harleysville, NJ, US | Sep 10, 15 - Sep 19, 17 |
| Harleysville, PA | Dec 30, 03 - Dec 25, 08 |
| Harleysville, PA, US | Nov 27, 03 - Jan 09, 25 |
| Harleyville, PA, US | Dec 23, 10 - May 07, 13 |
| New York, NY | Jul 03, 07 - Sep 18, 07 |
| New York, NY, US | Apr 18, 02 - Apr 18, 02 |
| Raritan, NJ, US | Jul 28, 22 - Aug 11, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 4 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 84 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 31 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0011,326 | 2025 | FUSED HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF HBV INFECTION | 0 |
| 2024/0287,070 | 2024 | FUSED HETEROCYCLIC DERIVATIVES | 0 |
| 2024/0279,227 | 2024 | FUSED HETEROCYCLIC DERIVATIVES | 0 |
| 2022/0348,592 | 2022 | FUSED HETEROCYCLIC DERIVATIVES | 0 |
| 2022/0323,455 | 2022 | FUSED HETEROCYCLIC DERIVATIVES AS ANTIVIRAL AGENTS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.